Search bioRxiv⌕ Search

bioRxiv · 10.1101/2023.10.13.562179

Cortactin interacts with αDystrobrevin-1 and regulates neuromuscular junction morphology

Abstract

BackgroundNeuromuscular junctions allow for transmitting signals from the nervous system to skeletal muscles, triggering their contraction, and their proper organization is essential for breathing and voluntary movements. Dystrobrevin-1 is a cytoplasmic component of the dystrophin-glycoprotein complex and has pivotal functions in regulating the integrity of muscle fibres and neuromuscular junctions. Previous studies identified that Dystrobrevin-1 functions in the organization of the neuromuscular junction and that its phosphorylation in the C-terminus is required in this process. MethodsWe used synthetic peptides corresponding to the phosphorylated tyrosine Y730 at the C-terminal part of Dystrobrevin-1 to precipitate interacting proteins from homogenate of differentiated muscle cells. Isolated proteins were identified by mass spectrometry, and co-immunoprecipitation and bimolecular fluorescence complementation experiments in skeletal muscles were used to validate interactions. We used immunohistochemical analysis and muscle electroporation to study cortactin localization in skeletal muscles. To study the function of cortactin in the neuromuscular system, we used cortactin KO mice. Synaptic morphology was studied using unbiased automatic image analysis, and muscle strength was assessed in grip-strength experiments and an animals ability to run on voluntary wheels and a treadmill. ResultsOur proteomic screen identified a number of putative Dystrobrevin-1 interactors recruited to the Y730 site in both its phosphorylated and unphosphorylated state. Amongst various actin regulators, we identified the Arp2/3 complex regulator cortactin. We showed that similarly to Dystrobrevin-1, cortactin is strongly enriched at the neuromuscular postsynaptic machinery and obtained results suggesting that these two proteins interact in cell homogenates and at the neuromuscular junctions. Analysis of synaptic morphology cortactin knockout mice showed abnormalities in the slow-twitching soleus muscle and not in the fast-twitching tibialis. However, muscle strength examination did not reveal apparent deficits in knockout animals. ConclusionsOur studies identified cortactin as a novel interactor of the dystrophin-glycoprotein complex, pivotal in maintaining muscle and neuromuscular junction integrity. We have shown that cortactin is a novel postsynaptic machinery component that can be essential in organizing the neuromuscular junctions.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

De Cicco, T., Pezinski, M., Wojcicka, O., Rottner, K., Proszynski, T.. 2023-10-17. Cortactin interacts with αDystrobrevin-1 and regulates neuromuscular junction morphology. https://doi.org/10.1101/2023.10.13.562179

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗